• Explore /
  • Poster
  • / KEYMAKER-U06 substudy 06A trial in progress: A phase 1/2 study of investigational agents with pembrolizumab (pembro) plus chemotherapy (chemo) or lenvatinib in PD-1/L1 treatment-naïve advanced esophageal cancer.

KEYMAKER-U06 substudy 06A trial in progress: A phase 1/2 study of investigational agents with pembrolizumab (pembro) plus chemotherapy (chemo) or lenvatinib in PD-1/L1 treatment-naïve advanced esophageal cancer.

Abstract Poster

Authors

Ken Kato

Ken Kato

National Cancer Center Hospital, Tokyo, Japan;

Ken Kato , Toshihiko Doi , Jaafar Bennouna , Jong-Mu Sun , Thomas Jemielita , Kanu Sharan , Pooja Bhagia , Antoine Adenis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05342636

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr TPS487)

DOI

10.1200/JCO.2023.41.4_suppl.TPS487

Abstract #

TPS487

Poster Bd #

P2

Abstract Disclosures

Similar Posters

First Author: Robert J. Motzer

First Author: Elizabeth R. Plimack

First Author: Deirdre Jill Cohen

First Author: Sheng Li